Peter Nell Email & Phone Number

Peter Nell is a Co-founder, CEO, President at Stealth Mode Biotech based in San Francisco, California, United States, North America. Building on a solid scientific background as co-inventor of letermovir and neladenoson, I added experience in building companies, business development and licensing, corporate strategy, commercial, alliance management, project management, financing and equity, and many other aspects along the drug discovery process. My background covers small molecules, biologics, and gene and cell therapy. I have worked for ten years in Europe and fourteen years in US. With my strong personal skills in communication, negotiation, strategic thinking, leadership and networking, I gained increasing responsibility at Bayer HealthCare while taken various positions in global locations. In 2016, I co-founded Casebia Tx, a JV between Bayer and CRISPR Tx, the CRISPR company co-founded by Emmanuelle Charpentier. After the successful acquisition of 100% of the partnership interests in Casebia by CRISPR Tx, I joined Mammoth Biosciences, co-founded by Jennifer Doudna, as Chief Business Officer and Head of Therapeutics Strategy. I continue to follow my passion for DNA and RNA editing by exploring new companies in the space and consulting and advising several early stage companies with an additional focus on AI. I have spoken at various public events, government institutions and on conference panels on aspects of gene therapy and gene editing. I am a Program Committee member for the 2025 ASGCT (American Society for Gene and Cell Therapy) meeting in New Orleans.